What a disappointing PR, first of all referring to
Post# of 36564
(Total Views: 317)
Posted On: 03/19/2020 10:40:52 AM
What a disappointing PR, first of all referring to the GNBT website will scare people away, it doesnt look professional at all, glad to see Omar Gzouli is still on board, maybe he can raise some funds.
This PR is a little too late for to boost the stock, maybe when the hype started it could have helped. No financial benefit at all, instead of any US company showing up with a check we are trying BARDA and hopefully receive funds !!! By the time we complete whatever is being worked on Big Pharma will look in the rear view mirror and may see a little dim light !! Hopefully we are ready for the next event although im sure companies are working hard to prevent another surprise. China is a risk, im sure they would like to tech but royalty payments ........
How about not getting distracted and an update regarding Altucell, funding, institutional interest , Analysts and IPO on track? Maybe expedite Q-report too. The lack of solid information continous and it reflects the PPS. Let us know the company has sufficient funds to complete all scheduled projects for 2020.
This PR is a little too late for to boost the stock, maybe when the hype started it could have helped. No financial benefit at all, instead of any US company showing up with a check we are trying BARDA and hopefully receive funds !!! By the time we complete whatever is being worked on Big Pharma will look in the rear view mirror and may see a little dim light !! Hopefully we are ready for the next event although im sure companies are working hard to prevent another surprise. China is a risk, im sure they would like to tech but royalty payments ........
How about not getting distracted and an update regarding Altucell, funding, institutional interest , Analysts and IPO on track? Maybe expedite Q-report too. The lack of solid information continous and it reflects the PPS. Let us know the company has sufficient funds to complete all scheduled projects for 2020.
(0)
(0)